HANNAH WUELLNER: Open Payments
NPI 1245977040 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 17 payments from 11 companies in 2025. Trend: 2023 $303 · 2024 $400 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 2 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Verona Pharma, Inc. | 2 | $42 |
| Insmed, Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $24 |
| United Therapeutics Corporation | 1 | $22 |
| GENZYME CORPORATION | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $16 |
Products named: Prolastin-C Liquid, DUPIXENT, Ohtuvayre, Arikayce, MOUNJARO, BREZTRI, Tyvaso, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
